In future studies, the pharmacological manipulation of PACAP using selective agonists/antagonists and region-specific interventions in areas such as the BNST and amygdala is needed to dissociate emotional versus feeding circuits, which have implications relevant to stress-related eating disorders, obesity, and mood disorders in humans. The gene discussed is ADCYAP1; the disease is mood disorder.